Features
AI agent (Gene) collaborates on trial themes and case strategy
Single source of truth for case facts, record, production, and strategy
Proactively flags facts that bolster or weaken trial themes
Early identification of appellate issues
Predicts opposing counsel moves
Hypothesis testing before expert hours are billed
Expert review workflow: AI tests, experts attest
Rapid onboarding of new counsel to case knowledge
Catching contradictions in new filings instantly
Deposition and cross-examination outline generation
Integration with email inbox for seamless workflow
Air-gapped AI agents (no arbitrary internet communication)
Data privacy: Cobbery cannot see user files or conversations
Isolated infrastructure per matter
Proprietary Recursion OS platform for drug discovery
Automated wet lab generating millions of cell experiments per week
Over 50 petabytes of biological and chemical data
NVIDIA BioHive-2 supercomputer for AI model training
Hit identification to IND-enabling studies with improved speed and cost
Potential first-in-class treatments in oncology and rare diseases
Advanced pipeline with phase 1/2/3 clinical trials (REC-4881, REC-3565)
Target identification and validation using machine learning
Generative AI for molecule design and optimization
De-identified patient data integration for precision medicine
Strategic partnerships with pharma and tech leaders
End-to-end drug development capability from preclinical to pivotal studies
Fit-for-purpose dataset generation including ADME and safety profiling
Real-world evidence generation through clinical trials
Continuous feedback loop from experiments into AI models
